William H. Conrad, Ph.D.
Affiliations: | Pharmacology | University of Washington, Seattle, Seattle, WA |
Area:
Wnt signalingGoogle:
"William Conrad"Mean distance: 17.6 (cluster 11) | S | N | B | C | P |
Parents
Sign in to add mentor| Randall Moon | grad student | 2012 | University of Washington | |
| (Resolving mechanisms of apoptosis in response to WNT3A in Melanoma.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Conrad W, Major MB, Cleary MA, et al. (2013) FAM129B is a novel regulator of Wnt/β-catenin signal transduction in melanoma cells. F1000research. 2: 134 |
| Conrad WH, Swift RD, Biechele TL, et al. (2012) Regulating the response to targeted MEK inhibition in melanoma: enhancing apoptosis in NRAS- and BRAF-mutant melanoma cells with Wnt/β-catenin activation. Cell Cycle (Georgetown, Tex.). 11: 3724-30 |
| Kategaya LS, Changkakoty B, Biechele T, et al. (2009) Bili inhibits Wnt/beta-catenin signaling by regulating the recruitment of axin to LRP6. Plos One. 4: e6129 |
| James RG, Biechele TL, Conrad WH, et al. (2009) Bruton's tyrosine kinase revealed as a negative regulator of Wnt-beta-catenin signaling. Science Signaling. 2: ra25 |
| Louie SH, Yang XY, Conrad WH, et al. (2009) Modulation of the beta-catenin signaling pathway by the dishevelled-associated protein Hipk1. Plos One. 4: e4310 |
| Chien AJ, Conrad WH, Moon RT. (2009) A Wnt survival guide: from flies to human disease. The Journal of Investigative Dermatology. 129: 1614-27 |
| James RG, Conrad WH, Moon RT. (2008) Beta-catenin-independent Wnt pathways: signals, core proteins, and effectors. Methods in Molecular Biology (Clifton, N.J.). 468: 131-44 |